Segment Information (Tables)

3 Months Ended

Dec. 31, 2019

Segment Reporting [Abstract]

Financial Information for Business Segments

The following is the summary of the financial information for the Company’s reportable segments for the three months ended December 31, 2019 and 2018 (in thousands):

			Three Months Ended December 31, 2019
				2019		2018
Revenue:
Brooks Semiconductor Solutions Group			$	118,811	$	112,707
Brooks Life Sciences				91,689		66,661
Total revenue			$	210,500	$	179,368
Operating income:
Brooks Semiconductor Solutions Group			$	15,000	$	17,263
Brooks Life Sciences				5,974		2,660
Reportable segment adjusted operating income				20,974		19,923
Amortization of completed technology				2,674		2,007
Acquisition accounting impact on inventory contracts acquired				—		184
Amortization of acquired intangible assets				7,910		5,769
Restructuring charges				576		59
Other unallocated corporate (income) expenses				(852)		6,571
Total operating income				10,666		5,333
Interest income				699		423
Interest expense				(737)		(5,290)
Other expenses, net				(417)		(30)
Income before income taxes			$	10,211	$	436
		Brooks
		Semiconductor		Brooks
Assets:		Solutions Group		Life Sciences		Total
December 31, 2019	$	267,221	$	932,613	$	1,199,834
September 30, 2019		259,641		909,154		1,168,795

Reconciliation of Reportable Segment Assets to Corresponding Consolidated Amounts

	December 31,		September 30,
	2019		2019
Segment assets	$	1,199,834	$	1,168,795
Cash, cash equivalents, restricted cash, and marketable securities		353,120		342,140
Deferred tax assets		6,004		5,064
Total assets	$	1,558,958	$	1,515,999